Clinical Trials Browser

Interventional × Primary Breast Cancer × Docetaxel × Clear all

NCT04127019 2020-02-26

Adjuvant 6 Cycles of Docetaxel and Cyclophosphamide or 3 Cycles of Cyclophosphamide/Epirubicin/Fluorouracil Followed by 3 Cycles of Docetaxel Versus 4 Cycles of Epirubicin and Cyclophosphamide Followed by Weekly Paclitaxel in Operable Breast Cancer (MASTER)

Phase 3 Completed

Primary Breast Cancer

NCT01049425 2019-08-14

planB

Phase 3 Completed

Primary Breast Cancer

NCT00527449 2010-01-15

ETCat01

Phase 2 Completed

Primary Breast Cancer

NCT00793377 2008-11-19

Neoadjuvant Doxorubicin/Cyclophosphamide Followed by Docetaxel (AC-Doc) Versus Dose-Dense Doxorubicin and Docetaxel (ADoc) in Breast Cancer

Phase 3 Completed

Primary Breast Cancer